Human Molecular Genetics, 2002, Vol. 11, No. 2 115-124
© 2002 Oxford University Press
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
1Department of Molecular and Human Genetics, 2Department of Pathology, 3Department of Pediatrics and 4Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Previous data have shown that MECP2 RNA is present in all mouse and human tissues tested, but the timing of expression and regional distribution have not been explored. We investigated the spatial and temporal distribution of the MeCP2 protein during mouse and human development. We found that in the adult mouse, MeCP2 is high in the brain, lung and spleen, lower in heart and kidney, and barely detectable in liver, stomach and small intestine. There was no obvious correlation between protein levels and RNA levels, suggesting that translation may be post-transcriptionally regulated by tissue-specific factors. The timing of MeCP2 expression in mouse and human correlated with the maturation of the central nervous system, with the ontogenetically older structures such as the spinal cord and brainstem becoming positive before newer structures such as the hippocampus and cerebral cortex. In the cortex, MeCP2 first appeared in the Cajal–Retzius cells, then in the neurons of the deeper, more mature cortical layers, and finally in the neurons of the more superficial layers. The MeCP2 protein was eventually present in a majority of neurons but was absent from glial cells. Our data suggest that MeCP2 may become abundant only once a neuron has reached a certain degree of maturity, and that this may explain some aspects of the RTT phenotype.
+ To whom correspondence should be addressed at: Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. Tel: +1 713 798 6523; Fax: +1 713 798 8728; Email: hzoghbi@bcm.tmc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Maezawa, S. Swanberg, D. Harvey, J. M. LaSalle, and L.-W. Jin Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions J. Neurosci., April 22, 2009; 29(16): 5051 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Abuhatzira, R. Shemer, and A. Razin MeCP2 involvement in the regulation of neuronal {alpha}-tubulin production Hum. Mol. Genet., April 15, 2009; 18(8): 1415 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Adachi, A. E. Autry, H. E. Covington III, and L. M. Monteggia MeCP2-Mediated Transcription Repression in the Basolateral Amygdala May Underlie Heightened Anxiety in a Mouse Model of Rett Syndrome J. Neurosci., April 1, 2009; 29(13): 4218 - 4227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fischer, J. Reuter, F. J. Gerich, B. Hildebrandt, S. Hagele, D. Katschinski, and M. Muller Enhanced Hypoxia Susceptibility in Hippocampal Slices From a Mouse Model of Rett Syndrome J Neurophysiol, February 1, 2009; 101(2): 1016 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Singh, A. Saxena, J. Christodoulou, and D. Ravine MECP2 genomic structure and function: insights from ENCODE Nucleic Acids Res., November 1, 2008; 36(19): 6035 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rusconi, L. Salvatoni, L. Giudici, I. Bertani, C. Kilstrup-Nielsen, V. Broccoli, and N. Landsberger CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail J. Biol. Chem., October 31, 2008; 283(44): 30101 - 30111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Namihira, J. Kohyama, M. Abematsu, and K. Nakashima Epigenetic mechanisms regulating fate specification of neural stem cells Phil Trans R Soc B, June 27, 2008; 363(1500): 2099 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nomura, M. Kimura, T. Horii, S. Morita, H. Soejima, S. Kudo, and I. Hatada MeCP2-dependent repression of an imprinted miR-184 released by depolarization Hum. Mol. Genet., April 15, 2008; 17(8): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Nelson, E. T. Kavalali, and L. M. Monteggia Activity-Dependent Suppression of Miniature Neurotransmission through the Regulation of DNA Methylation J. Neurosci., January 9, 2008; 28(2): 395 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Medrihan, E. Tantalaki, G. Aramuni, V. Sargsyan, I. Dudanova, M. Missler, and W. Zhang Early Defects of GABAergic Synapses in the Brain Stem of a MeCP2 Mouse Model of Rett Syndrome J Neurophysiol, January 1, 2008; 99(1): 112 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alvarez-Saavedra, M. A. Saez, D. Kang, H. Y. Zoghbi, and J. I. Young Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis Hum. Mol. Genet., October 1, 2007; 16(19): 2315 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Nan, J. Hou, A. Maclean, J. Nasir, M. J. Lafuente, X. Shu, S. Kriaucionis, and A. Bird Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation PNAS, February 20, 2007; 104(8): 2709 - 2714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peddada, D. H. Yasui, and J. M. LaSalle Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome Hum. Mol. Genet., June 15, 2006; 15(12): 2003 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M.B. Carvalho, W. Camargos, and S. D.J. Pena Multiplex Protocol Suitable for Screening for MECP2 Mutations in Girls with Mental Retardation. Clin. Chem., March 1, 2006; 52(3): 539 - 540. [Full Text] [PDF]
|
|
|
|
|
|
J. I. Young, E. P. Hong, J. C. Castle, J. Crespo-Barreto, A. B. Bowman, M. F. Rose, D. Kang, R. Richman, J. M. Johnson, S. Berget, et al. Inaugural Article: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2 PNAS, December 6, 2005; 102(49): 17551 - 17558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Adachi, E. W. Keefer, and F. S. Jones A segment of the Mecp2 promoter is sufficient to drive expression in neurons Hum. Mol. Genet., December 1, 2005; 14(23): 3709 - 3722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Duncan Armstrong Neuropathology of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 747 - 753. [Abstract] [PDF]
|
|
|
|
|
|
N. Kishi and J. D. Macklis Dissecting MECP2 Function in the Central Nervous System J Child Neurol, September 1, 2005; 20(9): 753 - 759. [Abstract] [PDF]
|
|
|
|
|
|
M. V. Johnston, M. E. Blue, and S. Naidu Rett Syndrome and Neuronal Development J Child Neurol, September 1, 2005; 20(9): 759 - 763. [Abstract] [PDF]
|
|
|
|
|
|
D. D. Armstrong Neuropathology of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 747 - 753. [Abstract] [PDF]
|
|
|
|
|
|
N. Kishi and J. D. Macklis Dissecting MECP2 Function in the Central Nervous System J Child Neurol, August 1, 2005; 20(8): 753 - 759. [Abstract] [PDF]
|
|
|
|
|
|
M. V. Johnston, M. E. Blue, and S. Naidu Rett Syndrome and Neuronal Development J Child Neurol, August 1, 2005; 20(8): 759 - 763. [Abstract] [PDF]
|
|
|
|
|
|
U. A. Nuber, S. Kriaucionis, T. C. Roloff, J. Guy, J. Selfridge, C. Steinhoff, R. Schulz, B. Lipkowitz, H. H. Ropers, M. C. Holmes, et al. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome Hum. Mol. Genet., August 1, 2005; 14(15): 2247 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mari, S. Azimonti, I. Bertani, F. Bolognese, E. Colombo, R. Caselli, E. Scala, I. Longo, S. Grosso, C. Pescucci, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome Hum. Mol. Genet., July 15, 2005; 14(14): 1935 - 1946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Watson, G. J. Pelka, T. Radziewic, M. D. Shahbazian, J. Christodoulou, S. L. Williamson, and P. P.L. Tam Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation Hum. Mol. Genet., July 1, 2005; 14(13): 1851 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Caballero and B. Hendrich MeCP2 in neurons: closing in on the causes of Rett syndrome Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R19 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Thatcher, S. Peddada, D. H. Yasui, and J. M. LaSalle Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples Hum. Mol. Genet., March 15, 2005; 14(6): 785 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L S Weaving, C J Ellaway, J Gecz, and J Christodoulou Rett syndrome: clinical review and genetic update J. Med. Genet., January 1, 2005; 42(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Dotti, F. Guideri, M. Acampa, A. Orrico, C. Battisti, and A. Federico Autonomic Dysfunction in Mental Retardation and Spastic Paraparesis With MECP2 Mutation J Child Neurol, December 1, 2004; 19(12): 964 - 966. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Collins, J. M. Levenson, A. P. Vilaythong, R. Richman, D. L. Armstrong, J. L. Noebels, J. David Sweatt, and H. Y. Zoghbi Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet., November 1, 2004; 13(21): 2679 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Braunschweig, T. Simcox, R. C. Samaco, and J. M. LaSalle X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain Hum. Mol. Genet., June 15, 2004; 13(12): 1275 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Luikenhuis, E. Giacometti, C. F. Beard, and R. Jaenisch Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice PNAS, April 20, 2004; 101(16): 6033 - 6038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Neul and H. Y. Zoghbi Rett Syndrome: A Prototypical Neurodevelopmental Disorder Neuroscientist, April 1, 2004; 10(2): 118 - 128. [Abstract] [PDF]
|
|
|
|
|
|
R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. BIRD and D. MACLEOD Reading the DNA Methylation Signal Cold Spring Harb Symp Quant Biol, January 1, 2004; 69(0): 113 - 118. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Y. Zoghbi Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? Science, October 31, 2003; 302(5646): 826 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kriaucionis and A. Bird DNA methylation and Rett syndrome Hum. Mol. Genet., October 15, 2003; 12(90002): R221 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Naidu, G. Bibat, L. Kratz, R. I. Kelley, J. Pevsner, E. Hoffman, C. Cuffari, C. Rohde, M. E. Blue, and M. V. Johnston Clinical Variability in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 662 - 668. [Abstract] [PDF]
|
|
|
|
|
|
M. H. Jarrar, C. G. Danko, S. Reddy, Y.-J. M. Lee, G. Bibat, and W. E. Kaufmann MeCP2 Expression in Human Cerebral Cortex and Lymphoid Cells: Immunochemical Characterization of a Novel Higher-Molecular-Weight Form J Child Neurol, October 1, 2003; 18(10): 675 - 682. [Abstract] [PDF]
|
|
|
|
|
|
D. Duncan Armstrong, K. Deguchi, and B. Antallfy Survey of MeCP2 in the Rett Syndrome and the Non--Rett Syndrome Brain J Child Neurol, October 1, 2003; 18(10): 683 - 687. [Abstract] [PDF]
|
|
|
|
|
|
M. V. Johnston, B. Mullaney, and M. E. Blue Neurobiology of Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 688 - 692. [Abstract] [PDF]
|
|
|
|
|
|
S. Akbarian The Neurobiology of Rett Syndrome Neuroscientist, February 1, 2003; 9(1): 57 - 63. [Abstract] [PDF]
|
|